Literature DB >> 6106520

Do drugs change the course of rheumatoid arthritis?

V Wright, R Amos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6106520      PMCID: PMC1601115          DOI: 10.1136/bmj.280.6219.964-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  19 in total

1.  Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis.

Authors:  E B HAMILTON; J T SCOTT
Journal:  Arthritis Rheum       Date:  1962-10

2.  Deleterious effect of intra-articular hydrocortisone.

Authors:  G N CHANDLER; V WRIGHT
Journal:  Lancet       Date:  1958-09-27       Impact factor: 79.321

3.  The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants.

Authors:  B McConkey; R A Crockson; A P Crockson
Journal:  Q J Med       Date:  1972-04

4.  Specificity of a low free serum histidine concentration for rheumatoid arthritis.

Authors:  D A Gerber; M G Gerber
Journal:  J Chronic Dis       Date:  1977-02

5.  Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis.

Authors:  B McConkey; P Davies; R A Crockson; A P Crockson; M Butler; T J Constable; R S Amos
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

6.  Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.

Authors:  A J Dixon; J Davies; T L Dormandy; E B Hamilton; P J Holt; R M Mason; M Thompson; J C Weber; D W Zutshi
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

7.  Azathioprine in rheumatoid arthritis.

Authors:  M Mason; H L Currey; C G Barnes; J F Dunne; B L Hazleman; I D Strickland
Journal:  Br Med J       Date:  1969-02-15

8.  Treatment of rheumatoid arthritis with levamisole. A controlled trial.

Authors:  L A Runge; R S Pinals; S H Lourie; R H Tomar
Journal:  Arthritis Rheum       Date:  1977 Nov-Dec

9.  Low free serum histidine concentration in rheumatoid arthritis. A measure of disease activity.

Authors:  D A Gerber
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

10.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11
View more
  26 in total

Review 1.  What should we hope to achieve when treating rheumatoid arthritis?

Authors:  D L Scott; T D Spector; T Pullar; B McConkey
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

Review 2.  Combination chemotherapy in rheumatoid arthritis.

Authors:  P M Brooks; A C Schwarzer
Journal:  Ann Rheum Dis       Date:  1991-07       Impact factor: 19.103

3.  A review of non-steroidal anti-inflammatory drugs.

Authors:  D Rosenbloom; M A Craven
Journal:  Can Fam Physician       Date:  1983-11       Impact factor: 3.275

4.  Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipoxygenase and cyclooxygenase.

Authors:  M J DiMartino; D E Griswold; B A Berkowitz; G Poste; N Hanna
Journal:  Agents Actions       Date:  1987-02

Review 5.  Inflammation and rheumatoid arthritis.

Authors:  Amit Kumar Shrivastava; Aparna Pandey
Journal:  J Physiol Biochem       Date:  2012-10-31       Impact factor: 4.158

6.  Effect of indomethacin on swelling, lymphocyte influx, and cartilage proteoglycan depletion in experimental arthritis.

Authors:  E R Pettipher; B Henderson; J C Edwards; G A Higgs
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

7.  Leucocyte infiltration and cartilage proteoglycan loss in immune arthritis in the rabbit.

Authors:  E R Pettipher; B Henderson; S Moncada; G A Higgs
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

8.  Rheumatoid inflammation and joint destruction: cause and effect or parallel phenomena?

Authors:  J D Williams; D L Scott; F B DeBrito; D A Willoughby; E C Huskisson
Journal:  Agents Actions       Date:  1986-08

9.  A modified mouse air pouch model for evaluating the effects of compounds on granuloma induced cartilage degradation.

Authors:  K M Bottomley; R J Griffiths; T J Rising; A Steward
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

10.  Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C.

Authors:  K Hashimoto; C E Whitehurst; T Matsubara; K Hirohata; P E Lipsky
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.